Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yasar Torres-Yaghi

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Handbook of Clinical Neurology|September 27, 2017
The diagnosis and natural history of Huntington diseaseFernando Pagan, Yasar Torres-Yaghi, Marcelle Altshuler
Current Pain and Headache Reports|March 31, 2015
Cardiac cephalgiaYasar Torres-Yaghi, Justin Salerian, Carrie Dougherty
BMC Neurology|November 25, 2025
Safety and efficacy of pimavanserin in patients with Lewy body dementia experiencing dementia-related psychosis in the HARMONY studyYasar Torres-Yaghi, Lambros Chrones, Victor Abler, et al.
Toxins|November 4, 2020
Sialorrhea in Parkinson's DiseaseJonathan Isaacson, Sanskruti Patel, Yasar Torres-Yaghi, et al.
Clinical Parkinsonism & Related Disorders|August 13, 2025
How to dose extended-release carbidopa-levodopa capsules (IPX203, CREXONT®) in patients with Parkinson's diseaseRobert A Hauser, Yasar Torres-Yaghi, Stanley Fisher, et al.
Parkinsonism & Related Disorders|July 30, 2023
Importance of time to ON versus wearing OFF in total daily OFF time experienced by patients with Parkinson's diseaseStuart H Isaacson, Daniel Kremens, Yasar Torres-Yaghi, et al.
CNS Drugs|April 8, 2024
On the Optimal Diagnosis and the Evolving Role of Pimavanserin in Parkinson's Disease PsychosisFernando L Pagan, Paul E Schulz, Yasar Torres-Yaghi, et al.
Neuropsychiatric Disease and Treatment|January 7, 2022
QTc Interval Prolongation with Therapies Used to Treat Patients with Parkinson's Disease Psychosis: A Narrative ReviewYasar Torres-Yaghi, Amelia Carwin, Jacob Carolan, et al.
Neurology. Clinical Practice|August 15, 2018
Reader response: Pimavanserin: A novel therapeutic option for Parkinson disease psychosisAbigail C Keys Lawler, Yasar Torres-Yaghi, Fahd Amjad, et al.
Neurology and Therapy|July 29, 2022
Screening, Diagnosis, and Management of Parkinson's Disease Psychosis: Recommendations From an Expert PanelRajesh Pahwa, Stuart H Isaacson, Gary W Small, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Handbook of Clinical Neurology|September 27, 2017
The diagnosis and natural history of Huntington diseaseFernando Pagan, Yasar Torres-Yaghi, Marcelle Altshuler
Current Pain and Headache Reports|March 31, 2015
Cardiac cephalgiaYasar Torres-Yaghi, Justin Salerian, Carrie Dougherty
BMC Neurology|November 25, 2025
Safety and efficacy of pimavanserin in patients with Lewy body dementia experiencing dementia-related psychosis in the HARMONY studyYasar Torres-Yaghi, Lambros Chrones, Victor Abler, et al.
Toxins|November 4, 2020
Sialorrhea in Parkinson's DiseaseJonathan Isaacson, Sanskruti Patel, Yasar Torres-Yaghi, et al.
Clinical Parkinsonism & Related Disorders|August 13, 2025
How to dose extended-release carbidopa-levodopa capsules (IPX203, CREXONT®) in patients with Parkinson's diseaseRobert A Hauser, Yasar Torres-Yaghi, Stanley Fisher, et al.
Parkinsonism & Related Disorders|July 30, 2023
Importance of time to ON versus wearing OFF in total daily OFF time experienced by patients with Parkinson's diseaseStuart H Isaacson, Daniel Kremens, Yasar Torres-Yaghi, et al.
CNS Drugs|April 8, 2024
On the Optimal Diagnosis and the Evolving Role of Pimavanserin in Parkinson's Disease PsychosisFernando L Pagan, Paul E Schulz, Yasar Torres-Yaghi, et al.
Neuropsychiatric Disease and Treatment|January 7, 2022
QTc Interval Prolongation with Therapies Used to Treat Patients with Parkinson's Disease Psychosis: A Narrative ReviewYasar Torres-Yaghi, Amelia Carwin, Jacob Carolan, et al.
Neurology. Clinical Practice|August 15, 2018
Reader response: Pimavanserin: A novel therapeutic option for Parkinson disease psychosisAbigail C Keys Lawler, Yasar Torres-Yaghi, Fahd Amjad, et al.
Neurology and Therapy|July 29, 2022
Screening, Diagnosis, and Management of Parkinson's Disease Psychosis: Recommendations From an Expert PanelRajesh Pahwa, Stuart H Isaacson, Gary W Small, et al.
Pageof 3